Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Endocrinol. doi: /nrendo

Published byAgus Irawan Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Endocrinol. doi: /nrendo"— Presentation transcript:

1 Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.76
Figure 3 Distribution of oncogenic alterations in anaplastic thyroid carcinoma Figure 3 | Distribution of oncogenic alterations in anaplastic thyroid carcinoma. Data from Landa et al.45 showing the distribution of oncogenic alterations in anaplastic thyroid carcinoma (ATC). a | The prevalence of the number of different oncogenic alterations in ATC. b | The prevalence of the distribution of multiple single-nucleotide variants (SNVs) in ATC, including SNVs in BRAF, TERT, RAS and other genes. Molinaro, E. et al. (2017) Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies Nat. Rev. Endocrinol. doi: /nrendo

Download ppt "Nat. Rev. Endocrinol. doi: /nrendo"

Similar presentations

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Childhood craniopharyngioma

Figure 3 Childhood craniopharyngioma
Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Figure 2 Regions of Africa exposed to undernutrition

Figure 2 Regions of Africa exposed to undernutrition
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 2 Pathophysiology of hyperglycaemia in T2DM

Figure 2 Pathophysiology of hyperglycaemia in T2DM
with undiagnosed diabetes mellitus by three diagnostic criteria

with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 4 Amino acid structure of short-acting and long-acting insulins

Figure 4 Amino acid structure of short-acting and long-acting insulins
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Figure 1 Mendelian randomization study

Figure 1 Mendelian randomization study
Figure 1 Adverse effects in women treated with HRT

Figure 1 Adverse effects in women treated with HRT
Figure 1 Monogenic forms of diabetes mellitus

Figure 1 Monogenic forms of diabetes mellitus
Figure 1 Current treatments for PNETs

Figure 1 Current treatments for PNETs
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Rheumatol. doi: /nrrheum

Nat. Rev. Rheumatol. doi: /nrrheum
Figure 1 The Beckwith–Wiedemann spectrum

Figure 1 The Beckwith–Wiedemann spectrum

Similar presentations

Ads by Google